Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2020 Sep;93(3):346-354.
doi: 10.1111/cen.14267. Epub 2020 Jul 15.

Comparative meta-analysis of Kabuki syndrome with and without hyperinsulinaemic hypoglycaemia

Henrike Hoermann  1 , Omar El-Rifai  2   3 , Martin Schebek  4 , Maria Lodefalk  5 , Klaus Brusgaard  3   6 , Nadine Bachmann  7 , Carsten Bergmann  7 , Marcia Roeper  1 , Alena Welters  1 , Roschan Salimi Dafsari  1 , Oliver Blankenstein  8 , Ertan Mayatepek  1 , Henrik Christesen  2   3   9 , Thomas Meissner  1 , Sebastian Kummer  1
Affiliations
Meta-Analysis

Comparative meta-analysis of Kabuki syndrome with and without hyperinsulinaemic hypoglycaemia

Henrike Hoermann et al. Clin Endocrinol (Oxf). 2020 Sep.

Abstract

Background and objective: Kabuki syndrome (KS), caused by pathogenic variants in KMT2D or KDM6A, is associated with hyperinsulinaemic hypoglycaemia (HH) in 0.3%-4% of patients. We characterized the clinical, biochemical and molecular data of children with KS and HH compared to children with KS without HH in a multicentre meta-analysis.

Methods: Data of seven new and 17 already published children with KS and HH were compared to 373 recently published KS patients without HH regarding molecular and clinical characteristics.

Results: Seven new patients were identified with seven different pathogenic variants in KDM6A (n = 4) or KMT2D (n = 3). All presented with HH on the first day of life and were responsive to diazoxide. KS was diagnosed between 9 months and 14 years of age. In the meta-analysis, 24 KS patients with HH had a significantly higher frequency of variants in KDM6A compared to 373 KS patients without HH (50% vs 11.5%, P < .001), and KDM6A-KS was more likely to be associated with HH than KMT2D-KS (21.8% vs. 3.5%, P < .001). Sex distribution and other phenotypic features did not differ between KS with and without HH.

Conclusion: The higher incidence of HH in KDM6A-KS compared to KMT2D-KS indicates that KDM6A loss of function variants predispose more specifically to beta cell dysfunction compared to KMT2D variants. As difficulties to assign syndromic characteristics to KS in early infancy often lead to delayed diagnosis, genetic testing for KS should be considered in children with HH, especially in the presence of other extrapancreatic/syndromic features.

Keywords: KDM6A; KMT2D; Kabuki syndrome; diazoxide; hyperinsulinism; hypoglycaemia; medical genetics.

PubMed Disclaimer

References

REFERENCES

    1. Steinkrauss L, Lipman TH, Hendell CD, Gerdes M, Thornton PS, Stanley CA. Effects of hypoglycemia on developmental outcome in children with congenital hyperinsulinism. J Pediatr Nurs. 2005;20:109-118.
    1. Galcheva S, Demirbilek H, Al-Khawaga S, Hussain K. The genetic and molecular mechanisms of congenital hyperinsulinism. Frontiers in endocrinology. 2019;10:111.
    1. Toda N, Ihara K, Kojima-Ishii K, et al. Hyperinsulinemic hypoglycemia in Beckwith-Wiedemann, Sotos, and Kabuki syndromes: a nationwide survey in Japan. Am J Med Genet A. 2017;173:360-367.
    1. Yap KL, Johnson AEK, Fischer D, et al. Congenital hyperinsulinism as the presenting feature of Kabuki syndrome: clinical and molecular characterization of 9 affected individuals. Genet Med. 2019;21:233-242.
    1. Weksberg R, Shuman C, Beckwith JB. Beckwith-Wiedemann syndrome. Eur J Human Genet. 2010;18:8-14.

Publication types

Supplementary concepts